Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Calcitonin Salmon. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR known ✓ | P30988 | 4/20 | 0.62 |
| ▸ | INSR | P06213 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 15/20 | 0.63 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.62 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.62 |
| ▸ | RAMP2 | O60895 | 1/20 | 0.62 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.62 |
| ▸ | NPY4R | P50391 | 7/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.61 |
| ▸ | NPY1R | P25929 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Calcitonin Salmon SCHEMBL29392873 | 1.00 | INSR (0.64) | INSRNPY2RRAMP3CALCRRAMP1 | |
| SCHEMBL30888738 | 0.97 | NPY2R (0.63) | INSRNPY2RRAMP3CALCRRAMP1 | |
| Calcitonin Salmon SCHEMBL29360745 | 0.94 | CALCR (0.69) | INSRNPY2RRAMP3CALCRRAMP1 | |
| SCHEMBL29500562 | 0.92 | CALCR (0.68) | INSRNPY2RRAMP3CALCRRAMP1 | |
| SCHEMBL268255 | 0.92 | NPY2R (0.60) | INSRNPY2RRAMP3CALCRNPY4R | |
| Davalintide SCHEMBL29533482 | 0.89 | RAMP1 (0.77) | INSRNPY2RRAMP3CALCRRAMP1 | |
| Elcitonin SCHEMBL29380850 | 0.89 | NPY2R (0.60) | NPY2RRAMP3CALCRNPY4RNPY5R | |
| SCHEMBL29374480 | 0.86 | CALCR (0.73) | NPY2RRAMP3CALCRRAMP1RAMP2 | |
| Calcitonin Human SCHEMBL29381354 | 0.86 | INSR (0.63) | INSRNPY2RRAMP3CALCRRAMP1 | |
| Elcatonin SCHEMBL29361233 | 0.86 | CALCR (0.64) | NPY2RRAMP3CALCRRAMP1RAMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15456 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144877-A1 | HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS | MANNKIND CORPORATION (US) | 2026-05-28 | — | — | US | claimed |
| CN-120943928-B | Human calcitonin modification method, modified human calcitonin and application thereof | 井冈山大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122031661-A | Application of calcitonin in improving hypoxia tolerance of fish | 海南省种业实验室 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099249-A1 | MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION | PAM THERAGNOSTICS GMBH (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4739283-A1 | PEPTIDE STEREOCOMPLEXATION WITH BIODEGRADABLE STEREOREGULAR POLYESTERS IN WATER AND HYDROGEL FORMS THEREOF | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. (IL) | 2026-05-13 | — | — | EP | claimed |
| US-12624128-B2 | Low molecular weight chondroitin sulfate, composition, preparation method and use thereof | Nanjing Hanxin Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-12 | — | — | US | claimed |
| US-20260124148-A1 | POLYPEPTIDE FORMULATIONS FOR ORAL DELIVERY | BHAMIS RES LABORATORY PVT LTD (IN) | 2026-05-07 | — | — | US | claimed |
| EP-4736147-A1 | LIVE ELECTRONIC TABLE GAME CASINO PIT WITH HYBRID DEALER ASSISTANCE | Interblock D.O.O. (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| WO-2026090327-A1 | A PEPTIDE COMPOSITION FOR CANCER APPROACH AND DIAGNOSIS | NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) | 2026-04-30 | — | — | WO | claimed |
| EP-3950962-A2 | METHOD FOR DIAGNOSING CANCER USING CFDNA | Genopsy, Inc. (KR) | 2022-02-09 | — | — | EP | claimed |
| US-11241395-B2 | Use of procalcitonin (PCT) in risk stratification and prognosis of patients with a primary, non-infectious disease | B.R.A.H.M.S. GMBH (DE) | 2022-02-08 | — | — | US | claimed |
| US-11241549-B2 | Dry powder inhaler and system for drug delivery | MANNKIND CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| CN-114026265-A | Apparatus for forming a plurality of coated particles, method for forming a plurality of coated particles, coated particles | 南爱克萨股份公司 | 2022-02-08 | — | — | CN | claimed |
| CN-114026107-A | Production of disulfide peptides | 巴克姆股份公司 | 2022-02-08 | — | — | CN | claimed |
| US-20220031596-A1 | ANTI-AGING AGENT AND ANTI-AGING METHOD | TANAKA MEGUMI (JP) | 2022-02-03 | — | — | US | claimed |
| US-20220024922-A1 | PYRROLO - DIPYRIDINE COMPOUNDS | OSSIFI THERAPEUTICS LLC | 2022-01-27 | — | — | US | claimed |
| EP-3003342-B1 | ENZYME-CATALYZED SYNTHESIS OF SITE-SPECIFIC AND STOICHIOMETRIC BIOMOLECULE-POLYMER CONJUGATES | UNIV DUKE (US) | 2022-01-26 | — | — | EP | claimed |
| US-11230595-B2 | Methods for treating osteogenesis imperfecta | GENZYME CORPORATION (US) | 2022-01-25 | — | — | US | claimed |
| CN-113960235-A | Application and method of biomarker in preparation of lung cancer detection reagent | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2022-01-21 | — | — | CN | claimed |